Monday Morning Update 11/3/25

Top News

Waystar reports Q3 results: revenue up 12%, EPS $0.17 versus $0.03, beating expectations for both.

WAY shares are up 73% since its June 2024 IPO, valuing the company at $7 billion.

CEO Matthew Hawkins said in the earnings call that Waystar’s $1.25 billion acquisition of Iodine Software in October 2025 extends its data coverage across all RCM phases and will enable development of AI-based products that autonomously manage revenue cycle functions.

Reader Comments

From Decent Undercarriage: “Re: Epic consulting. Redditors are discussing a LinkedIn post that says Epic is calling out certified analysts who are billing multiple clients, aka double dippers.” A since-removed LinkedIn post claims that Epic is sending quarterly reports to health system executives that list employees and consultants who are using multiple logins across organizations. The author says some of those folks have been terminated without a chance to explain their situation, even when their extra hours were legitimate, such as moonlighting. The post also refers to individuals who are billing 160 or more hours per week.

HIStalk Announcements and Requests

I think most poll respondents recognize the achievement of earning a doctorate in anything. However, more than half say that hospitals should limit the title’s use to medical doctors.

New poll to your right or here: Do health systems create a conflict of interest by promoting or using technology from for-profit companies that they partly own? I’ve noticed a trend of posting glowing press releases about successful technology rollouts at major health systems, only to find in the fine print that the health system is also an investor in the company and thus unlikely to utter a discouraging word.  

It’s that annual time when I pretend to be a performative marketer instead of a hospital IT nerd lifer whose hobby is spending part of every day filling blank computer screens. If your company has been meaning to sponsor HIStalk “someday,” this is your nudge to do so before December 31. You get free months, startup perks, and a special nod if you are a former sponsor who returns to my little fold. Email Lorre while I’m briefly focused on feeding the financial beast of keeping HIStalk running instead of obsessing over writing it.

Sponsored Events and Resources

None scheduled soon. Contact Lorre to have your resource listed.

Acquisitions, Funding, Business, and Stock

Virginia Commonwealth University pursues the purchase of a 450,000-square-foot former tobacco company building to house drug and cancer research and to increase the capacity of its public health and pharmacy programs.

Health insurers will fight profit-sapping medical costs by using AI to counter what they say is the AI-driven aggressive claims coding of providers.

You may be unaware that private equity firms own an increasing percentage of US hospices. You may be unsurprised that their hospices make the most money, spend less on patient care, and shift care to nursing facilities whenever possible to push medical costs onto someone else.

Announcements and Implementations

A Black Book Research survey of health tech vendor executives finds that health system cash worries, many of them triggered by the federal government’s shutdown, are prompting project pauses, RFP delays, and a shift toward revenue-producing initiatives. 

A study finds that asynchronous, text-based depression therapy is just as effective as real-time video sessions. Most insurers don’t cover it, however.

OpenAI says that it will deliver an AI intern-level research assistant by September 2026 and a fully capable scientific researcher by 2028, also predicting that deep learning systems will reach superintelligence — systems that are smarter than humans — within the next decade.

Privacy and Security

Yale New Haven Health System will pay $18 million to settle a class action lawsuit related to a March 2025 cybersecurity breach that affected 5.5 million patients. The health system has not confirmed reports that the attack involved ransomware.

Other

Dilbert creator Scott Adams will ask President Trump to intervene in his quest to obtain chemotherapy for prostate cancer. A course of Pluvicto costs about $300,000. Clinical trials showed that it extended average survival from 11 months to 15 months, although other studies found that the drug had no impact on lifespan.

Sponsor Updates

• Black Book Research releases new reports on the state of healthcare laboratory information for Europe and North America.
• Netsmart adds Rectangle Health’s payment software to its TheraOffice EHR and practice management software.
• Agfa HealthCare will exhibit and present at RSNA 2025 November 30-December 4 in Chicago.
• Nordic releases a new “Designing for Health” podcast featuring Will Morris.
• Nym publishes a new case study titled “Genesis HealthCare System’s Autonomous Coding Success Story.”
• Inovalon will showcase expanded platform capabilities and feature enhancements at its annual Empower healthcare summit November 2-4 in Washington, DC.
• WellSky will exhibit at the America’s Physician Group Fall Conference November 5-7 in National Harbor, MD.

Blog Posts

• 5 rural healthcare organizations helping their communities thrive (Meditech)
• 8 Referral Management Strategies to Drive Growth in Human Services (Netsmart)
• Stop designing for everyone: How personas improve healthcare technology (Nordic)
• Turning Policy Change into Member Action: How MA Plans Can Lead in the New CMS Era (ReferWell)
• How Nurse Leaders Drive Change & Advance Strategic Goals (Symplr)
• From evidence to AI: Why provenance matters in clinical decision support (Wolters Kluwer Health)

Contacts

Mr. H, Lorre, Jenn, Dr. Jayne.
Get HIStalk updates.
Send news or rumors.
Follow on X, Bluesky, and LinkedIn.
Sponsorship information.
Contact us.